1-2 of 2
Peter Brown, DPhil
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a Phase II Study with Bendamustine and Ofatumumab in Untreated Indolent B-Cell Non-Hodgkin's Lymphoma

Nathan H. Fowler, MD, Stephen P. Kahanic, MD, Andres Forero, MD, Mihaela C. Munteanu, MS, Glen L. Davis, MS, Peter Brown, DPhil, Eric Van Den Neste, MD, Fritz C. Offner, MD, PhD, Dominique Bron, MD, Myron S. Czuczman, MD
Journal: Blood
Blood (2011) 118 (21): 778.
https://doi.org/10.1182/blood.V118.21.778.778
Published: 2011
Journal Articles

Assessment of Targeted Systemic Exposure Based on Ex-Vivo Concentrations of Bendamustine and Chlorambucil and Related Clinical Outcomes

Mona Darwish, PhD, Peter Brown, DPhil, Debra M Bensen-Kennedy, MD, Lauren Young
Journal: Blood
Blood (2008) 112 (11): 4211.
https://doi.org/10.1182/blood.V112.11.4211.4211
Published: 2008